Andrea Denker is Professor of "Accelerator Physics for Medicine"

Prof. Dr. Andrea Denker is the head of the department "Proton Therapy" at HZB.

Prof. Dr. Andrea Denker is the head of the department "Proton Therapy" at HZB. © HZB/ M. Setzpfandt

The Beuth Hochschule für Technik Berlin and the Helmholtz-Zentrum Berlin (HZB) have appointed Prof. Dr. Andrea Denker to the joint professorship "Accelerator Physics for Medicine" as of October 1, 2018. Since 2006, Andrea Denker is head of the department "Proton Therapy" at the HZB, which operates the accelerator for eye tumor therapy. The therapy, offered in cooperation with the Charité - Universitätsmedizin Berlin and the HZB, is unique in Germany.

As part of her professorship, Andrea Denker is taking on lectures in the "Physical Technology - Medical Physics" course at Beuth University. In the current winter semester she offers the lecture "Atomic and Nuclear Physics" for Bachelor students.

Even before her appointment, Andrea Denker was a lecturer at the university. "I enjoy this job very much and the contact with the students is very enriching for me and my team at HZB," says Denker. The appointment now creates an even closer connection to the university. "We are already looking forward to many interesting theses that will be written at the proton accelerator at the HZB.

Andrea Denker studied and received her doctorate in physics at the University of Stuttgart. Then she worked at the CSNSM (Centre de Sciences Nucléaires et de Sciences de la Matière) in Orsay, France. In 1995 Andrea Denker started as a scientist at the ion accelerator ISL. Among other things, she calculated and developed the beam parameters for eye tumor therapy, which was launched 20 years ago.

(sz)

  • Copy link

You might also be interested in

  • Berlin Battery Lab: BAM, HZB and HU are conducting joint research on sodium batteries
    News
    19.03.2026
    Berlin Battery Lab: BAM, HZB and HU are conducting joint research on sodium batteries
    The Federal Institute for Materials Research and Testing (BAM), the Helmholtz Zentrum Berlin (HZB) and Humboldt-Universität zu Berlin (HU) today officially inaugurated the Berlin Battery Lab (BBL). At this new research platform, BAM, HZB and HU jointly develop and test resource-efficient battery technologies with a focus on sodium-based systems. Together, they develop new materials, investigate innovative cell chemistries, and produce battery prototypes. The research infrastructure of the Berlin Battery Lab is also open to external partners from science and industry and is designed to accelerate the transfer from research to application.
  • Humboldt-Fellow at HZB Institute for Solar Fuels: Kayode Adesina Adegoke
    News
    18.03.2026
    Humboldt-Fellow at HZB Institute for Solar Fuels: Kayode Adesina Adegoke
    Kayode Adesina Adegoke is a renowned chemist, affiliated with LAUTECH SDG 11 (Sustainable Cities and Communities Research Group), Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, Ogbomoso, Nigeria. He is collaborating with Matthew Mayer to investigate the degradation of electrocatalysts during electrochemical CO₂ reduction. The Alexander von Humboldt Fellowship enables him to stay at Helmholtz Zentrum Berlin up to 24 months.
  • A duo for BESSY III light source
    News
    10.03.2026
    A duo for BESSY III light source
    Since 1 March 2026, Renske van der Veen and Andreas Jankowiak have formed the leadership team of BESSY III. Together, they will drive forward HZB’s central project: the planning and realisation of BESSY III light source in Berlin-Adlershof. Here, they talk about their motivation, the next steps, and why BESSY III is a a cross-generational project.